Apyx Medical Corporation

Apyx Medical Corporation

BVX
Apyx Medical CorporationUS flagNASDAQ Global Select
6.48
USD
-0.01
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Charles D. Goodwin II
Full Time Employees
220
Sector
Healthcare
Industry
Medical - Devices
Address
5115 Ulmerton Road Clearwater FL United States of America 33760
IPO Date
Jan 1, 1987
Business
Apyx Medical Corporation (Nasdaq: APYX), an advanced energy technology company, designs, develops, manufactures and markets innovative electrosurgical equipment and medical devices for surgical and cosmetic procedures in the United States and internationally. The company operates through two segments, Advanced Energy and Original Equipment Manufacturer (OEM); the Advanced Energy segment offers helium plasma technology products marketed as Renuvion for cosmetic surgery applications, providing plastic surgeons, facial plastic surgeons and cosmetic physicians with controlled subdermal tissue heating to achieve skin tightening and body contouring results, and as J-Plasma for hospital surgical markets, enabling precise cutting, coagulation and ablation of soft tissue during open and minimally invasive procedures using a helium plasma generator, single-use handpieces and helium gas accessories; the OEM segment produces electrosurgical generators, medical devices and related accessories for third-party medical device manufacturers and start-ups. Apyx Medical, formerly Bovie Medical Corporation, was founded in 1982 and is headquartered in Clearwater, Florida, with a manufacturing facility in Bulgaria serving as its European authorized service center. The company recently launched commercial U.S. sales of the AYON Body Contouring System, the industry's first all-in-one surgical platform integrating Renuvion helium plasma technology with monopolar and bipolar energy, adaptive touch screens, procedural presets and power liposuction capabilities following FDA 510(k) clearance in May 2025 and a label expansion submission in October 2025; initiated Renuvion distribution in China through a partnership with GlamMoon Medical Technology in July 2025; appointed key sales executives in August 2025 to drive global expansion of Renuvion and AYON; raised full-year 2025 revenue guidance to $50.5 million-$52.5 million; and completed a $10 million public offering of common stock in November 2025.

Company News

APIChat
  • CME Is Launching a Bitcoin VIX: Here's Why That Changes Wall Street's Bitcoin Game

  • Bovie Medical (NYSEAMERICAN:BVX) Stock Price Passes Above Fifty Day Moving Average – What’s Next?

  • Bovie Medical (NYSEAMERICAN:BVX) Stock Passes Below 50-Day Moving Average – Here’s Why

  • Bovie Medical (NYSEAMERICAN:BVX) Share Price Passes Below Fifty Day Moving Average – Should You Sell?